Business Context and Reporting Period
This Form 8-K is a current report filed by PharmAthene, Inc. (not Altimmune, Inc.) on March 30, 2009. The filing announces the company's financial results for the fiscal year ended December 31, 2008. The report serves to disseminate a press release furnished as Exhibit 99.1.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are referenced as being contained within the press release (Exhibit 99.1) but are not included in the body of this 8-K document.
Material Changes
The filing does not provide specific data to compare against prior periods. It solely references the issuance of the annual results press release.
Guidance, Outlook, and Risks
The document contains no management commentary, forward-looking guidance, or specific risk factors within the text provided. It includes a standard disclaimer stating that the information in this report and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the correct registrant name is PharmAthene, Inc., as the input metadata incorrectly listed Altimmune, Inc.
- Locate and review Exhibit 99.1 (the press release dated March 30, 2009) to obtain actual financial figures for the fiscal year ended December 31, 2008.
- Confirm the company's principal executive office address: One Park Place, Suite 450, Annapolis, Maryland 21401.
- Note that this 8-K filing itself does not contain audited financial statements or detailed operational metrics.